Lotemax SM (loteprednol etabonate ophthalmic gel 0.38%) / Bausch Health  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lotemax SM (loteprednol etabonate ophthalmic gel 0.38%) / Bausch Health
NCT01996839 / 2005-003578-55: Loteprednol Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

Completed
3
514
US
Loteprednol Etabonate Gel (BID), Lotemax, Loteprednol Etabonate Gel (TID), Vehicle (BID), Vehicle, Vehicle (TID)
Bausch & Lomb Incorporated
Inflammation, Pain, Cataract
05/14
07/14
NCT02208297 / 2013-002049-13: Loteprednol Etabonate Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

Completed
3
326
US
Loteprednol Etabonate Gel (BID), Lotemax, Vehicle Gel (BID), Vehicle
Bausch & Lomb Incorporated
Inflammation, Pain, Cataract
03/15
03/15

Download Options